US Stock MarketDetailed Quotes
SGRY Surgery Partners
- 29.240
- -0.080-0.27%
Trading Nov 7 09:33 ET
3.72BMarket Cap-112461P/E (TTM)
29.455High29.110Low4.26KVolume29.420Open29.320Pre Close124.94KTurnover0.01%Turnover RatioLossP/E (Static)127.12MShares36.91552wk High1.90P/B2.21BFloat Cap22.25052wk Low--Dividend TTM75.58MShs Float69.580Historical High--Div YieldTTM1.18%Amplitude4.000Historical Low29.309Avg Price1Lot Size
Surgery Partners Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.93%82.8M | -45.37%40.7M | 85.01%293.8M | 769.44%62.6M | 252.19%104.6M | 23.75%52.1M | -6.64%74.5M | 82.32%158.8M | -63.45%7.2M | 99.33%29.7M |
| Net income from continuing operations | -50.78%28.4M | 1,925.00%24.3M | 55.52%135.3M | 100.43%46.7M | 430.36%29.7M | 277.12%57.7M | -97.20%1.2M | 23.06%87M | -45.69%23.3M | -31.71%5.6M |
| Operating gains losses | 202.13%9.6M | -75.73%2.5M | 14.46%27.7M | 6.51%22.9M | 85.71%3.9M | -687.50%-9.4M | 1,130.00%10.3M | 110.43%24.2M | 10,650.00%21.5M | 5.00%2.1M |
| Depreciation and amortization | 42.62%34.8M | 0.00%33.7M | 2.87%118.1M | 5.07%31.1M | -3.02%28.9M | -12.86%24.4M | 22.99%33.7M | 16.19%114.8M | 30.40%29.6M | 18.25%29.8M |
| Deferred tax | 152.58%5.1M | 238.89%2.5M | -107.76%-1.7M | -4.21%9.1M | -90.67%700K | -348.72%-9.7M | -280.00%-1.8M | 146.07%21.9M | -15.18%9.5M | 733.33%7.5M |
| Other non cash items | -20.98%11.3M | -32.26%10.5M | 1,234.62%59M | 418.52%14M | 442.86%15.2M | 293.24%14.3M | 569.70%15.5M | 88.37%-5.2M | 142.86%2.7M | 190.32%2.8M |
| Change In working capital | 27.85%-21.5M | -430.70%-37.7M | 39.10%-62.3M | 22.52%-65.7M | 194.37%21.8M | -727.78%-29.8M | 23.91%11.4M | -35.50%-102.3M | -54.18%-84.8M | -3.13%-23.1M |
| -Change in receivables | -25.90%-17.5M | -38.64%5.4M | -33.71%-47.2M | 25.06%-29M | -555.00%-13.1M | -508.82%-13.9M | 340.00%8.8M | -9.97%-35.3M | -182.48%-38.7M | 86.93%-2M |
| -Change in other working capital | 74.84%-4M | -1,757.69%-43.1M | 77.46%-15.1M | 20.39%-36.7M | 265.40%34.9M | -127.14%-15.9M | -63.89%2.6M | -54.38%-67M | -11.62%-46.1M | -197.18%-21.1M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.93%82.8M | -45.37%40.7M | 85.01%293.8M | 769.44%62.6M | 252.19%104.6M | 23.75%52.1M | -6.64%74.5M | 82.32%158.8M | -63.45%7.2M | 99.33%29.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -242.84%-244.1M | -17.54%-83.1M | 26.73%-225.6M | 19.53%-58.1M | 52.85%-25.6M | 46.98%-71.2M | -50.11%-70.7M | 7.18%-307.9M | 62.00%-72.2M | 46.24%-54.3M |
| Net PPE purchase and sale | -249.35%-26.9M | -19.63%-19.5M | 6.94%-63M | -102.04%-19.8M | -10.98%-19.2M | 65.63%-7.7M | 10.44%-16.3M | -31.20%-67.7M | 7.55%-9.8M | -11.61%-17.3M |
| Net business purchase and sale | -394.47%-205.7M | -12.52%-56.6M | 43.64%-128.9M | 50.56%-30.9M | 83.51%-6.1M | 62.04%-41.6M | -156.63%-50.3M | 18.44%-228.7M | 65.16%-62.5M | 56.88%-37M |
| Net other investing changes | 47.49%-11.5M | -70.73%-7M | -193.04%-33.7M | -7,500.00%-7.4M | ---300K | -852.17%-21.9M | 55.91%-4.1M | -3,933.33%-11.5M | --100K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -242.84%-244.1M | -17.54%-83.1M | 26.73%-225.6M | 19.53%-58.1M | 52.85%-25.6M | 46.98%-71.2M | -50.11%-70.7M | 7.18%-307.9M | 62.00%-72.2M | 46.24%-54.3M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 486.94%189.6M | 176.94%31.7M | -468.65%-155.2M | -123.10%-44.6M | 57.50%-20.4M | 17.37%-49M | 5.72%-41.2M | -86.69%42.1M | -15.97%193.1M | 0.62%-48M |
| Net issuance payments of debt | 5,086.00%249.3M | --72.3M | 103.03%19.5M | 101.17%7.2M | 284.04%17.3M | 68.35%-5M | --0 | -1,370.78%-644.2M | -7,208.33%-613.9M | -40.30%-9.4M |
| Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 51.75%882.9M | ---- | ---- |
| Cash dividends paid | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | -35.68%-59.7M | 1.46%-40.6M | 11.14%-174.7M | 31.75%-51.8M | 2.33%-37.7M | -1.15%-44M | -6.74%-41.2M | 9.23%-196.6M | 8.22%-75.9M | 7.21%-38.6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 486.94%189.6M | 176.94%31.7M | -468.65%-155.2M | -123.10%-44.6M | 57.50%-20.4M | 17.37%-49M | 5.72%-41.2M | -86.69%42.1M | -15.97%193.1M | 0.62%-48M |
| Net cash flow | ||||||||||
| Beginning cash position | -24.56%185.2M | -30.75%195.9M | -27.44%282.9M | 52.45%236M | -21.99%177.4M | -35.21%245.5M | -27.44%282.9M | 22.53%389.9M | -53.15%154.8M | -51.08%227.4M |
| Current changes in cash | 141.56%28.3M | 71.39%-10.7M | 18.69%-87M | -131.30%-40.1M | 180.72%58.6M | 55.05%-68.1M | -240.00%-37.4M | -249.23%-107M | 115.29%128.1M | 45.98%-72.6M |
| End cash Position | 20.35%213.5M | -24.56%185.2M | -30.75%195.9M | -30.75%195.9M | 52.45%236M | -21.99%177.4M | -35.21%245.5M | -27.44%282.9M | -27.44%282.9M | -53.15%154.8M |
| Free cash flow | 112.55%55.9M | -60.76%19.7M | 162.15%205M | 376.13%42.8M | 591.13%85.7M | 33.50%26.3M | -18.51%50.2M | 165.08%78.2M | -376.79%-15.5M | 2,166.67%12.4M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data